Corrigendum to "Anti-cancer potential of (1,2-dihydronaphtho[2,1-b]furan-2-yl)methanone derivatives" [Bioorg. Med. Chem. Lett. 30 (2020) 127476].
作者信息
Islam Kobirul, Pal Kunal, Debnath Utsab, Basha R Sidick, Khan Abu Taleb, Jana Kuladip, Misra Anup Kumar
机构信息
Bose Institute, Division of Molecular Medicine, P-1/12, C.I.T. Scheme VII M, Kolkata 700054, India; Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781 039, India.
Bose Institute, Division of Molecular Medicine, P-1/12, C.I.T. Scheme VII M, Kolkata 700054, India.
出版信息
Bioorg Med Chem Lett. 2021 Feb 15;34:127764. doi: 10.1016/j.bmcl.2020.127764. Epub 2021 Jan 2.
PMID:33401154
Abstract
摘要
相似文献
1
Corrigendum to "Anti-cancer potential of (1,2-dihydronaphtho[2,1-b]furan-2-yl)methanone derivatives" [Bioorg. Med. Chem. Lett. 30 (2020) 127476].《(1,2-二氢萘并[2,1-b]呋喃-2-基)甲酮衍生物的抗癌潜力》勘误 [《生物有机与药物化学快报》30 (2020) 127476]
Bioorg Med Chem Lett. 2021 Feb 15;34:127764. doi: 10.1016/j.bmcl.2020.127764. Epub 2021 Jan 2.
2
Corrigendum to "1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents" [Bioorg. Med. Chem. Lett. 27 (2017) 4471-4477].《“1-噻唑-2-基-N-3-甲基-1H-吡唑-5-羧酸衍生物作为抗肿瘤剂”的勘误》[《生物有机与药物化学快报》27 (2017) 4471 - 4477]
Bioorg Med Chem Lett. 2018 Mar 1;28(5):985. doi: 10.1016/j.bmcl.2018.01.046. Epub 2018 Feb 9.
3
Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057].
Bioorg Med Chem Lett. 2017 May 1;27(9):2081. doi: 10.1016/j.bmcl.2017.02.064. Epub 2017 Mar 20.
4
Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].《查耳酮衍生物作为抗炎剂的设计、合成、生物学评价及分子对接》的勘误 [《生物有机与药物化学快报》27 (3) (2017) 602 - 606]
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3822. doi: 10.1016/j.bmcl.2018.10.027. Epub 2018 Oct 30.
5
Corrigendum to "Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors" [Bioorg. Med. Chem. Lett. 31 (2021) 127710].对“鉴定2-取代吡咯并[1,2-b]哒嗪衍生物作为新型PARP-1抑制剂”[《生物有机与药物化学快报》31 (2021) 127710]的勘误
Bioorg Med Chem Lett. 2022 Jan 15;56:128501. doi: 10.1016/j.bmcl.2021.128501. Epub 2021 Dec 12.
6
Corrigendum to "Syntheses and antimicrobial activities of ogipeptin derivatives" [Bioorg. Med. Chem. Lett. 42 (2021) 128093].《奥吉肽素衍生物的合成及其抗菌活性》的勘误[《生物有机与药物化学快报》42 (2021) 128093]
Bioorg Med Chem Lett. 2021 Sep 1;47:128228. doi: 10.1016/j.bmcl.2021.128228. Epub 2021 Jun 27.
7
Corrigendum to 'Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase' [Bioorg. Med. Chem. Lett. 27 (2017) 1649-1653].
Bioorg Med Chem Lett. 2017 Sep 1;27(17):4218. doi: 10.1016/j.bmcl.2017.07.065. Epub 2017 Aug 2.
8
Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].《新型苯甲酰胺衍生物作为高效的Smoothened拮抗剂的合成及生物学评价》的勘误[《生物有机与药物化学快报》24/5 (2014) 1426 - 1431]
Bioorg Med Chem Lett. 2016 Sep 15;26(18):4558. doi: 10.1016/j.bmcl.2015.06.051. Epub 2016 Aug 16.
9
Corrigendum to "Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors" [Bioorg. Med. Chem. Lett. 53 (2021) 128409].《作为TRK抑制剂的大环衍生物的设计、合成及生物学评价》的勘误[《生物有机与药物化学快报》53 (2021) 128409]
Bioorg Med Chem Lett. 2022 Jan 15;56:128502. doi: 10.1016/j.bmcl.2021.128502. Epub 2021 Dec 11.
10
Corrigendum to "Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives" [Bioorg Med Chem Lett 27(16) (2017) 3920-3924].
Bioorg Med Chem Lett. 2019 Feb 1;29(3):515. doi: 10.1016/j.bmcl.2018.11.012. Epub 2018 Dec 19.
Zotero 插件